Literature DB >> 20923757

The clinical and genetic features of Huntington disease.

Aaron Sturrock1, Blair R Leavitt.   

Abstract

Huntington disease (HD) is a dominantly inherited neurodegenerative disorder that usually presents in adulthood with characteristic motor and cognitive features and with variable and diverse psychiatric disturbances. Following the discovery of the causative defect in the HTT gene in 1993, great advances in understanding the pathogenesis of HD have been made, yet no effective disease-modifying therapy has been identified. In this new era of HD research, we have seen the emergence of a number of large clinical trials, the systematic search for novel biomarkers and the recent initiation of the first pre-manifest HD clinical studies. In this review, we seek to provide an overview of the clinical and genetic features of HD together with a summary of clinical research at this time.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20923757     DOI: 10.1177/0891988710383573

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  39 in total

1.  Development of the HD-Teen Inventory.

Authors:  Martha Driessnack; Janet K Williams; J Jackson Barnette; Kathleen J Sparbel; Jane S Paulsen
Journal:  Clin Nurs Res       Date:  2011-06-01       Impact factor: 2.075

2.  Identification of a post-translationally myristoylated autophagy-inducing domain released by caspase cleavage of huntingtin.

Authors:  Dale D O Martin; Ryan J Heit; Megan C Yap; Michael W Davidson; Michael R Hayden; Luc G Berthiaume
Journal:  Hum Mol Genet       Date:  2014-01-23       Impact factor: 6.150

3.  Impact of Huntington Disease Gene-Positive Status on Pre-Symptomatic Young Adults and Recommendations for Genetic Counselors.

Authors:  Ping Gong; Joanna H Fanos; Lauren Korty; Carly E Siskind; Andrea K Hanson-Kahn
Journal:  J Genet Couns       Date:  2016-04-22       Impact factor: 2.537

Review 4.  Palmitoylation and depalmitoylation defects.

Authors:  Thorsten Hornemann
Journal:  J Inherit Metab Dis       Date:  2014-08-05       Impact factor: 4.982

5.  Striatal neurons expressing full-length mutant huntingtin exhibit decreased N-cadherin and altered neuritogenesis.

Authors:  Surya A Reis; Morgan N Thompson; Jong-Min Lee; Elisa Fossale; Hyung-Hwan Kim; James K Liao; Michael A Moskowitz; Stanley Y Shaw; Linda Dong; Stephen J Haggarty; Marcy E MacDonald; Ihn Sik Seong
Journal:  Hum Mol Genet       Date:  2011-03-29       Impact factor: 6.150

Review 6.  Therapeutic applications of antibodies in non-infectious neurodegenerative diseases.

Authors:  Pavan K Krishnamurthy; Einar M Sigurdsson
Journal:  N Biotechnol       Date:  2011-04-05       Impact factor: 5.079

Review 7.  A role for autophagy in Huntington's disease.

Authors:  Katherine R Croce; Ai Yamamoto
Journal:  Neurobiol Dis       Date:  2018-08-24       Impact factor: 5.996

8.  Strategies used by teens growing up in families with Huntington disease.

Authors:  Janet K Williams; Martha Driessnack; J Jackson Barnette; Kathleen J H Sparbel; Anne Leserman; Sean Thompson; Jane S Paulsen
Journal:  J Pediatr Nurs       Date:  2013-03-24       Impact factor: 2.145

9.  Two decades of Huntington disease testing: patient's demographics and reproductive choices.

Authors:  Rebekah C Krukenberg; Daniel L Koller; David D Weaver; Jennifer N Dickerson; Kimberly A Quaid
Journal:  J Genet Couns       Date:  2013-05-25       Impact factor: 2.537

10.  Huntington disease in the South African population occurs on diverse and ethnically distinct genetic haplotypes.

Authors:  Fiona K Baine; Chris Kay; Maria E Ketelaar; Jennifer A Collins; Alicia Semaka; Crystal N Doty; Amanda Krause; L Jacquie Greenberg; Michael R Hayden
Journal:  Eur J Hum Genet       Date:  2013-03-06       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.